JP2007518724A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007518724A5 JP2007518724A5 JP2006547586A JP2006547586A JP2007518724A5 JP 2007518724 A5 JP2007518724 A5 JP 2007518724A5 JP 2006547586 A JP2006547586 A JP 2006547586A JP 2006547586 A JP2006547586 A JP 2006547586A JP 2007518724 A5 JP2007518724 A5 JP 2007518724A5
- Authority
- JP
- Japan
- Prior art keywords
- gly
- pharmaceutical composition
- asp
- glu
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53373003P | 2003-12-31 | 2003-12-31 | |
| US60/533,730 | 2003-12-31 | ||
| PCT/US2004/044012 WO2005065706A1 (en) | 2003-12-31 | 2004-12-30 | Pharmaceutical composition for thrombin peptide derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007518724A JP2007518724A (ja) | 2007-07-12 |
| JP2007518724A5 true JP2007518724A5 (https=) | 2008-01-31 |
| JP5044829B2 JP5044829B2 (ja) | 2012-10-10 |
Family
ID=34652502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006547586A Expired - Lifetime JP5044829B2 (ja) | 2003-12-31 | 2004-12-30 | トロンビンペプチド誘導体のための医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7291596B2 (https=) |
| EP (1) | EP1559431B1 (https=) |
| JP (1) | JP5044829B2 (https=) |
| CN (1) | CN1913917B (https=) |
| AT (1) | ATE357928T1 (https=) |
| AU (1) | AU2004312090B2 (https=) |
| CA (1) | CA2551525C (https=) |
| DE (1) | DE602004005564T2 (https=) |
| DK (1) | DK1559431T3 (https=) |
| ES (1) | ES2287660T3 (https=) |
| PL (1) | PL1559431T3 (https=) |
| PT (1) | PT1559431E (https=) |
| WO (1) | WO2005065706A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60313982T2 (de) * | 2002-07-02 | 2008-01-17 | Orthologic Corp., Tempe | Dimere von thrombinpeptidderivaten |
| EP3067047B1 (en) | 2005-12-08 | 2022-04-20 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections |
| JP2010504336A (ja) * | 2006-09-22 | 2010-02-12 | オーソロジック コーポレイション | 血管内皮機能不全を治療する方法 |
| US8227412B2 (en) * | 2007-03-29 | 2012-07-24 | Tsopanoglou Nikos E | Bioactive parstatin peptides and methods of use |
| US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
| GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
| CA2722621A1 (en) * | 2008-03-26 | 2009-10-01 | Orthologic Corp. | Thrombin derived peptides for smooth muscle relaxation |
| US20110105400A1 (en) * | 2008-03-26 | 2011-05-05 | Orthologic Corp. | Methods for treating acute myocardial infarction |
| EP2280722A2 (en) * | 2008-03-26 | 2011-02-09 | Orthologic Corp. | Method of treating degenerative diseases |
| WO2009120307A2 (en) * | 2008-03-26 | 2009-10-01 | Orthologic Corp. | Method of treating peripheral arterial disease |
| US20110319340A1 (en) * | 2008-09-19 | 2011-12-29 | The Board Of Regents, The University Of Texas System | Methods for treating cancer |
| GB0821806D0 (en) | 2008-11-28 | 2009-01-07 | Circassia Ltd | Compositions with reduced dimer formation |
| WO2011106222A2 (en) | 2010-02-23 | 2011-09-01 | Corning Incorporated | Modified substrates for protection of peptide-immobilized surfaces from gamma radiation degradation |
| US10124066B2 (en) * | 2012-11-29 | 2018-11-13 | Insmed Incorporated | Stabilized vancomycin formulations |
| BR112016007382B1 (pt) * | 2013-10-03 | 2021-12-21 | Luis Alberto Améstica Salazar | Composição biocida de resinas que compreendem uma ou mais resinas selecionadas de resinas mf, uf, pf, muf e fenólicas; e mais de um sal de cobre solúvel |
| LT3466432T (lt) | 2014-05-15 | 2020-12-28 | Insmed Incorporated | Būdai, skirti plaučių netuberkuliozinėms mikobakterinėms infekcijoms gydyti |
| US10220078B2 (en) | 2014-06-11 | 2019-03-05 | The Board Of Regents Of The University Of Texas System | Methods of using thrombin derivatives to treat medulloblastoma |
| CN105879010A (zh) * | 2015-01-17 | 2016-08-24 | 内蒙古天奇生物科技有限公司 | 一种能促进创伤愈合减轻创后瘢痕的多肽组合物及其制备方法 |
| EP3773505B1 (en) | 2018-03-30 | 2026-04-29 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
| JP7449275B2 (ja) | 2018-05-02 | 2024-03-13 | インスメッド インコーポレイテッド | リポソーム薬物製剤の製造方法 |
| EP3952991A4 (en) * | 2019-04-12 | 2023-08-09 | Affirmed Pharma, LLC | RUSALATIDE ACETATE COMPOSITIONS |
| JP2023139750A (ja) * | 2022-03-22 | 2023-10-04 | 株式会社東芝 | 抗酸化剤を用いたｆｅｔセンサ |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3019612A1 (de) * | 1980-05-22 | 1981-11-26 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabilisiertes thrombinpraeparat |
| US5352664A (en) | 1986-10-31 | 1994-10-04 | Board Of Regents, The University Of Texas System | Thrombin derived polypeptides; compositions and methods for use |
| JP2000229882A (ja) * | 1998-12-10 | 2000-08-22 | Sankyo Co Ltd | 修飾シクロデキストリン含有トロンビン水性液剤 |
| GB9930768D0 (en) | 1999-12-29 | 2000-02-16 | Pfizer Ltd | Composition |
| TWI257307B (en) | 2000-07-12 | 2006-07-01 | Orthologic Corp | Pharmaceutical composition for cardiac tissue repair |
| ATE254925T1 (de) * | 2000-07-19 | 2003-12-15 | Univ Texas | Stimulierung des knochenwachstums mit peptidderivaten von thrombin |
| AU7356101A (en) * | 2000-07-20 | 2002-02-05 | Univ Texas | Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| AU2002223802A1 (en) * | 2000-11-17 | 2002-05-27 | Warner-Lambert Company Llc | Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| WO2002074806A2 (en) * | 2001-02-27 | 2002-09-26 | Maxygen Aps | New interferon beta-like molecules |
| ES2271216T3 (es) | 2001-07-27 | 2007-04-16 | Orthologic Corp. | Uso de los peptidos derivados de la trombina para la terapia de las ulceras dermicas cronicas. |
| ATE504311T1 (de) | 2002-01-16 | 2011-04-15 | Capstone Therapeutics Corp | Thrombin-derivierten peptiden zur förderung von herzgewebsreparatur |
| JP2005519067A (ja) | 2002-01-17 | 2005-06-30 | ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | トロンビンペプチド誘導体を用いた骨成長および軟骨形成の刺激 |
| WO2003092731A1 (en) * | 2002-05-03 | 2003-11-13 | Novo Nordisk A/S | Stabilised solid compositions of modified factor vii |
| DE60313982T2 (de) | 2002-07-02 | 2008-01-17 | Orthologic Corp., Tempe | Dimere von thrombinpeptidderivaten |
| AU2003256343B2 (en) * | 2002-07-02 | 2006-12-21 | Orthologic Corp. | Thrombin peptide derivatives |
-
2004
- 2004-12-30 CN CN2004800414872A patent/CN1913917B/zh not_active Expired - Fee Related
- 2004-12-30 CA CA2551525A patent/CA2551525C/en not_active Expired - Lifetime
- 2004-12-30 ES ES04258191T patent/ES2287660T3/es not_active Expired - Lifetime
- 2004-12-30 AU AU2004312090A patent/AU2004312090B2/en not_active Expired
- 2004-12-30 AT AT04258191T patent/ATE357928T1/de active
- 2004-12-30 US US11/027,923 patent/US7291596B2/en not_active Expired - Lifetime
- 2004-12-30 PL PL04258191T patent/PL1559431T3/pl unknown
- 2004-12-30 DK DK04258191T patent/DK1559431T3/da active
- 2004-12-30 EP EP04258191A patent/EP1559431B1/en not_active Expired - Lifetime
- 2004-12-30 JP JP2006547586A patent/JP5044829B2/ja not_active Expired - Lifetime
- 2004-12-30 DE DE602004005564T patent/DE602004005564T2/de not_active Expired - Lifetime
- 2004-12-30 WO PCT/US2004/044012 patent/WO2005065706A1/en not_active Ceased
- 2004-12-30 PT PT04258191T patent/PT1559431E/pt unknown
-
2007
- 2007-09-25 US US11/903,877 patent/US7875588B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007518724A5 (https=) | ||
| US11786491B2 (en) | Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders | |
| US12569456B2 (en) | Methods for the treatment of cysteamine sensitive disorders | |
| Veber et al. | The design of metabolically-stable peptide analogs | |
| JP6223377B2 (ja) | 長期間作用性ペプチド類似体のための組成物 | |
| Freidinger | Design and synthesis of novel bioactive peptides and peptidomimetics | |
| AU2004259028C1 (en) | Stable radiopharmaceutical compositions and methods for preparation | |
| US7875588B2 (en) | Methods of therapy using pharmaceutical composition for thrombin peptide derivatives | |
| JPH08508259A (ja) | 血栓症の阻害剤としてのα−ケトアミド誘導体 | |
| PT736039E (pt) | Compostos com propriedades para liberar a hormona de crescimento | |
| BRPI0717135B1 (pt) | Antagonista peptídico cíclico de somastotatina e composição farmacêutica | |
| RU2009111391A (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ чГР, ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ | |
| TWI243178B (en) | Novel somatostatin analogs | |
| JP2004521123A5 (https=) | ||
| RU2015108678A (ru) | Составы ангиотензина для перорального применения | |
| EP0667163A1 (en) | Powder for nasal administration of peptidic or proteinaceous drug | |
| JPWO1995003818A1 (ja) | ペプチド，蛋白質性薬物経鼻粉剤 | |
| EA200101108A1 (ru) | Полиморфные модификации кристаллического цитрата азабицикло[2.2.2]октан-3-амина и их фармацевтические композиции | |
| JP2017501967A (ja) | 新規なペプチド組成物 | |
| AR037943A1 (es) | Derivados de pirimidinilsulfonamida, el uso de dichos compuestos solo o en combinacion para la produccion de medicamentos y un proceso para la manufactura de composiciones farmaceuticas | |
| RU2009148036A (ru) | Способы и композиции для лечения фенилкетонурии | |
| RS51029B (sr) | Upotreba antagonista bradikinin-b2 receptora za lečenje osteoartroze | |
| DE602006016168D1 (de) | 1,3,5-triazepin-dionen zur Behandlung von Malaria | |
| jimoh Akanbi | Oral and pulmonary delivery of thioether-bridged angiotensin-(1–7 | |
| MXPA06000918A (es) | Composiciones radiofarmaceuticas estables y metodos para su preparacion |